The National Cancer Institute's Clinical Proteomic Technologies for Cancer Initiative this week issued a request for targets for monoclonal antibody production and characterization as part of its Antibody Characterization Program.

The organization will accept submissions through July 9 and will review them "based on their justification and contribution to existing NCI-funded projects," the request said. It added that "priority will be given to projects applying the antibodies to proteomics research."